![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ENY2 |
Gene summary for ENY2 |
![]() |
Gene information | Species | Human | Gene symbol | ENY2 | Gene ID | 56943 |
Gene name | ENY2 transcription and export complex 2 subunit | |
Gene Alias | DC6 | |
Cytomap | 8q23.1 | |
Gene Type | protein-coding | GO ID | GO:0001678 | UniProtAcc | Q9NPA8 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
56943 | ENY2 | GSM4909281 | Human | Breast | IDC | 6.05e-86 | 1.01e+00 | 0.21 |
56943 | ENY2 | GSM4909282 | Human | Breast | IDC | 2.02e-35 | 7.46e-01 | -0.0288 |
56943 | ENY2 | GSM4909285 | Human | Breast | IDC | 1.44e-15 | 4.58e-01 | 0.21 |
56943 | ENY2 | GSM4909286 | Human | Breast | IDC | 5.86e-04 | 2.45e-01 | 0.1081 |
56943 | ENY2 | GSM4909287 | Human | Breast | IDC | 2.12e-42 | 7.07e-01 | 0.2057 |
56943 | ENY2 | GSM4909288 | Human | Breast | IDC | 2.38e-06 | 3.31e-01 | 0.0988 |
56943 | ENY2 | GSM4909290 | Human | Breast | IDC | 2.86e-12 | 4.80e-01 | 0.2096 |
56943 | ENY2 | GSM4909291 | Human | Breast | IDC | 2.82e-05 | 3.67e-01 | 0.1753 |
56943 | ENY2 | GSM4909292 | Human | Breast | IDC | 4.99e-05 | 5.59e-01 | 0.1236 |
56943 | ENY2 | GSM4909293 | Human | Breast | IDC | 5.01e-03 | 2.58e-01 | 0.1581 |
56943 | ENY2 | GSM4909294 | Human | Breast | IDC | 5.33e-17 | 3.56e-01 | 0.2022 |
56943 | ENY2 | GSM4909295 | Human | Breast | IDC | 7.77e-03 | 3.47e-01 | 0.0898 |
56943 | ENY2 | GSM4909296 | Human | Breast | IDC | 1.21e-16 | 1.77e-01 | 0.1524 |
56943 | ENY2 | GSM4909297 | Human | Breast | IDC | 2.51e-22 | -2.58e-02 | 0.1517 |
56943 | ENY2 | GSM4909301 | Human | Breast | IDC | 8.09e-08 | 3.06e-01 | 0.1577 |
56943 | ENY2 | GSM4909304 | Human | Breast | IDC | 4.42e-07 | 3.69e-01 | 0.1636 |
56943 | ENY2 | GSM4909306 | Human | Breast | IDC | 5.15e-14 | 5.05e-01 | 0.1564 |
56943 | ENY2 | GSM4909307 | Human | Breast | IDC | 6.62e-04 | 2.57e-01 | 0.1569 |
56943 | ENY2 | GSM4909308 | Human | Breast | IDC | 1.15e-13 | 4.14e-01 | 0.158 |
56943 | ENY2 | GSM4909309 | Human | Breast | IDC | 3.12e-05 | 2.32e-01 | 0.0483 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:007133314 | Endometrium | EEC | cellular response to glucose stimulus | 39/2168 | 151/18723 | 9.34e-07 | 3.22e-05 | 39 |
GO:007133114 | Endometrium | EEC | cellular response to hexose stimulus | 39/2168 | 153/18723 | 1.33e-06 | 4.35e-05 | 39 |
GO:007132614 | Endometrium | EEC | cellular response to monosaccharide stimulus | 39/2168 | 154/18723 | 1.59e-06 | 4.96e-05 | 39 |
GO:004259314 | Endometrium | EEC | glucose homeostasis | 56/2168 | 258/18723 | 2.26e-06 | 6.61e-05 | 56 |
GO:003350014 | Endometrium | EEC | carbohydrate homeostasis | 56/2168 | 259/18723 | 2.56e-06 | 7.39e-05 | 56 |
GO:005065712 | Endometrium | EEC | nucleic acid transport | 39/2168 | 163/18723 | 7.00e-06 | 1.63e-04 | 39 |
GO:005065812 | Endometrium | EEC | RNA transport | 39/2168 | 163/18723 | 7.00e-06 | 1.63e-04 | 39 |
GO:005123612 | Endometrium | EEC | establishment of RNA localization | 39/2168 | 166/18723 | 1.11e-05 | 2.33e-04 | 39 |
GO:000691314 | Endometrium | EEC | nucleocytoplasmic transport | 59/2168 | 301/18723 | 3.31e-05 | 5.65e-04 | 59 |
GO:005116914 | Endometrium | EEC | nuclear transport | 59/2168 | 301/18723 | 3.31e-05 | 5.65e-04 | 59 |
GO:001593112 | Endometrium | EEC | nucleobase-containing compound transport | 46/2168 | 222/18723 | 5.91e-05 | 9.13e-04 | 46 |
GO:005116814 | Endometrium | EEC | nuclear export | 35/2168 | 154/18723 | 6.36e-05 | 9.48e-04 | 35 |
GO:006117811 | Endometrium | EEC | regulation of insulin secretion involved in cellular response to glucose stimulus | 19/2168 | 64/18723 | 7.55e-05 | 1.10e-03 | 19 |
GO:005105111 | Endometrium | EEC | negative regulation of transport | 80/2168 | 470/18723 | 2.53e-04 | 2.93e-03 | 80 |
GO:005102812 | Endometrium | EEC | mRNA transport | 29/2168 | 130/18723 | 3.63e-04 | 3.95e-03 | 29 |
GO:005070813 | Endometrium | EEC | regulation of protein secretion | 50/2168 | 268/18723 | 4.33e-04 | 4.51e-03 | 50 |
GO:003577311 | Endometrium | EEC | insulin secretion involved in cellular response to glucose stimulus | 19/2168 | 73/18723 | 4.96e-04 | 5.04e-03 | 19 |
GO:005079611 | Endometrium | EEC | regulation of insulin secretion | 32/2168 | 165/18723 | 2.30e-03 | 1.70e-02 | 32 |
GO:007169213 | Endometrium | EEC | protein localization to extracellular region | 59/2168 | 368/18723 | 5.98e-03 | 3.56e-02 | 59 |
GO:000930614 | Endometrium | EEC | protein secretion | 57/2168 | 359/18723 | 8.30e-03 | 4.57e-02 | 57 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ENY2 | SNV | Missense_Mutation | c.68N>T | p.Thr23Ile | p.T23I | Q9NPA8 | protein_coding | deleterious(0.02) | possibly_damaging(0.462) | TCGA-A6-6138-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
ENY2 | SNV | Missense_Mutation | c.61A>G | p.Ile21Val | p.I21V | Q9NPA8 | protein_coding | tolerated(0.53) | benign(0.005) | TCGA-NH-A5IV-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
ENY2 | SNV | Missense_Mutation | novel | c.41C>T | p.Ala14Val | p.A14V | Q9NPA8 | protein_coding | tolerated(0.06) | benign(0.379) | TCGA-AJ-A8CW-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
ENY2 | SNV | Missense_Mutation | rs754316009 | c.44N>T | p.Ala15Val | p.A15V | Q9NPA8 | protein_coding | tolerated(0.58) | benign(0) | TCGA-AP-A051-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
ENY2 | SNV | Missense_Mutation | novel | c.179N>G | p.Glu60Gly | p.E60G | Q9NPA8 | protein_coding | tolerated(0.08) | benign(0.098) | TCGA-AX-A2HC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | paclitaxel | PD |
ENY2 | SNV | Missense_Mutation | novel | c.298N>G | p.Ser100Gly | p.S100G | Q9NPA8 | protein_coding | tolerated(0.15) | benign(0) | TCGA-FI-A3PV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
ENY2 | SNV | Missense_Mutation | c.282N>A | p.Phe94Leu | p.F94L | Q9NPA8 | protein_coding | tolerated(0.07) | possibly_damaging(0.752) | TCGA-44-7670-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Chemotherapy | docetaxel | SD | |
ENY2 | SNV | Missense_Mutation | rs754316009 | c.44N>T | p.Ala15Val | p.A15V | Q9NPA8 | protein_coding | tolerated(0.58) | benign(0) | TCGA-86-A4JF-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Chemotherapy | unknown | PD |
ENY2 | SNV | Missense_Mutation | c.256G>C | p.Glu86Gln | p.E86Q | Q9NPA8 | protein_coding | deleterious(0) | benign(0.435) | TCGA-L9-A7SV-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Chemotherapy | cisplatin | CR | |
ENY2 | SNV | Missense_Mutation | novel | c.18N>A | p.Met6Ile | p.M6I | Q9NPA8 | protein_coding | tolerated(0.1) | benign(0.005) | TCGA-CV-6441-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | III/IV | Unknown | Unknown | PD |
Page: 1 2 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |